摘要
目的:探讨孕妇产前血液检测传染性标志物的临床意义。方法:采用微粒子化学发光技术检测乙型肝炎病毒标志物;酶联免疫法(ELISA)检测丙型肝炎病毒抗体(HCV)、梅毒螺旋体抗体(TP)、人类免疫缺陷病毒抗体(HIV)。结果:6170名孕妇中HBsAg阳性总人数593例,HBsAg阳性率9.61%;梅毒感染人数39例,梅毒抗体阳性率0.63%;丙肝感染人数18例,丙肝抗体阳性率0.29%;未检测出HIV阳性者。结论:孕妇产前血液传染性标志物的检测,能为阻断和降低母婴传播,确保母婴安全健康提供保障;减少和避免医疗纠纷、预防医院感染提供可靠的实验室依据。
Objective：To investigate the clinical significance of detection of infectious markers in blood of the pregnant women.Methods：Using the microparticle chemiluminescence technique to detect the infectious markers of hepatitis B virus（HBV） and the enzyme linked immunoadsorbent assay（ELISA） to detect the hepatitis C virus antibody（HCV）,treponema pallidum antibody（TP） and Human immunodeficiency virus antibody（HIV）.Results：593 cases in total 6170 pregnant women were positive for HBsAg and the positive rate was 9.61%,syphilis infections were 39 cases in total and the positive rate was 0.63%,HCV infections were 18 cases and the positive rate was 0.29%,and no case was positive for HIV.Conclusion：Detection of blood infectious markers in pregnant women can block and reduce the rate of mother-to-child transmission,protect maternal and fetal health and safety,provide the reliable laboratory basis for reducing and avoiding medical disputes and prevent hospital infection.
出处
《中国卫生检验杂志》
北大核心
2012年第4期785-786,共2页
Chinese Journal of Health Laboratory Technology
关键词
孕妇
传染病
母婴传播
医疗纠纷
医院感染
Pregnant women
Infectious disease
Mother-to-child Transmission
Medical dispute
Hospital infection
